RxDoctor Payments DataLook up a doctor →

Yevgeniy Bukhman

Internal Medicine · Canton, OHNPI 1336374503

Payments from drug & device makers

$3,744,353in general payments, 2019–2025

Across 830 payments — averaging $4511.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1.2M
  • Janssen Research & Development, LLC$1M
  • Pfizer$319K
  • Seqirus USA Inc$308K
  • Astrazeneca UK Limited$289K
  • Modernatx, Inc.$243K
  • plus $342K from 8 others
$118,133in research payments, 2019–2025

Across 23 payments — averaging $5136.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$116K
  • GSK$2K

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen9$1,224,470
Janssen Research & Development, LLC42$1,018,989
Pfizer22$318,966
Seqirus USA Inc292$307,961
Astrazeneca UK Limited3$289,042
Modernatx, Inc.343$242,818
Eli Lilly38$169,283
E.r. Squibb & Sons, L.L.C.5$57,756
Alnylam Pharmaceuticals Inc.42$34,558
AstraZeneca2$31,876
GSK16$29,292
Regeneron1$17,500
Merck11$1,390
Novo Nordisk4$451

How this compares

$3,744,353 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Other internal medicine in Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →